Scott Taber
About Scott Taber
Scott Taber is a researcher at the Saltzman Research Group at Yale University, where he focuses on cell cultures and nanoparticle drug delivery systems. He has a background in Molecular Biophysics and Biochemistry and has participated in various academic programs in Germany, Ireland, and California.
Work at Yale University
Scott Taber has been working as a researcher in the Saltzman Research Group at Yale University since 2020. His role involves conducting research with cell cultures and biochemical laboratory protocols. The Saltzman Research Group focuses on innovative approaches in drug delivery systems, particularly in the area of passive targeting nanoparticle systems. This position allows Taber to contribute to significant advancements in biomedical research within a prestigious academic environment.
Education and Expertise
Scott Taber has a solid educational background in the sciences. He studied Molecular Biophysics & Biochemistry at Yale University, where he earned his Bachelor of Science degree from 2018 to 2022. Prior to this, he completed an Academic Year Study Abroad Program at Schiller Gymnasium Hof in Bavaria, Germany, during the 2015-2016 academic year. Additionally, he participated in a Summer Study Abroad Program at University College Cork in 2019, further enhancing his academic experience.
Background
Scott Taber completed his secondary education at St. Paul's School, graduating with Summa Cum Laude honors in 2018. His academic journey includes diverse experiences, such as studying abroad in Germany and Ireland, which contributed to his global perspective in scientific research. His early exposure to various educational systems has shaped his approach to research and collaboration in the laboratory setting.
Research Experience
Before joining Yale University, Scott Taber gained practical research experience as a Summer Intern in the UCSB Research Mentorship Program at UC Santa Barbara in 2017. During this two-month internship, he engaged in hands-on research activities, which provided him with foundational skills in scientific inquiry and laboratory techniques. His current research focuses on nanoparticle drug delivery systems, reflecting his commitment to advancing the field of biochemistry.